Central Retinal Artery Occlusion

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Mechanism: Central Retinal Artery Occlusion (CRAO) is fundamentally an acute ischemic stroke equivalent of the eye. It is characterized by an embolic or thrombotic occlusion of the central retinal artery, resulting in a sudden "low-flow" state or total cessation of blood flow to the retina.
• The Breakdown: The sudden lack of perfusion causes rapid ischemia and subsequent retinal edema, which manifests visually as profound fundal paleness.
• The Foveal Exception: The fovea is anatomically unique; it does not develop this edema because it derives its blood supply from the underlying choroidal circulation rather than the central retinal artery. Consequently, the well-perfused fovea stands out against the surrounding pale, infarcted retina, creating the pathognomonic "cherry-red spot".
• Etiological Triggers: While primarily driven by atherosclerotic emboli, CRAO can also be directly caused by systemic vasculitis, most notably Giant Cell (Temporal) Arteritis.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Initial Resuscitation & ABCs: Acute vision loss in isolation is not life-threatening; however, because CRAO is a stroke equivalent, you must immediately prioritize and assess for concurrent acute embolic events, such as an acute cerebral stroke or limb ischemia.
• Immediate Medical Interventions: Attempts at restoring retinal perfusion must be initiated immediately.
• Digital Ocular Massage: Perform immediately to physically dislodge the embolus.
• IOP Reduction: Administer \(\beta\)-blocker eye drops and systemic diuretics to lower intraocular pressure and improve the perfusion gradient.
• Vasodilators: Administer vasodilator medications to encourage collateral flow.
• Advanced Reperfusion: Consider the administration of tissue plasminogen activator (tPA) for the lysis of the occluding thrombus, as many stroke centers are experimentally expanding their inclusion criteria for thrombolytics to include CRAO.
• Surgical Adjuncts: Anterior chamber paracentesis may be warranted to rapidly drop intraocular pressure, though this aggressive treatment rarely alters the notoriously poor prognosis.
• Special Considerations: If Giant Cell Arteritis is the suspected etiology, you must initiate early, high-dose intravenous corticosteroids and immunosuppressive agents to prevent bilateral blindness.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

Top "Can't-Miss" Differentials:

• Central Retinal Vein Occlusion (CRVO): Presents with painless vision loss, but fundoscopy reveals classic "blood and thunder" retinal hemorrhages rather than a pale retina.
• Retinal Detachment: Presents with painless vision loss, often preceded by flashes (photopsias) or a "curtain" over the visual field.
• Giant Cell Arteritis: A critical underlying cause of CRAO that must be ruled out, especially if the patient has a headache or temporal tenderness.
• Acute Angle-Closure Glaucoma: An ocular emergency, but distinctly painful with a steamy cornea and mid-dilated pupil.

Prioritized Diagnostic Workup:

• Visual Acuity: This is the absolute paramount initial test. You must obtain and formally document visual acuity for all patients with an ocular complaint.
• Pupillary Examination: Assess specifically for an afferent pupillary defect (Marcus Gunn pupil), which strongly suggests an optic nerve or severe retinal insult.
• Fundoscopy: The gold-standard bedside imaging modality to directly visualize the retina for paleness, emboli, or hemorrhages.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• The Fundoscopic Checklist: On direct visualization of the retina, the resident must look for:
• A profoundly pale, ischemic retina caused by edema.
• A prominent "cherry-red spot" at the fovea.
• Narrow and irregular retinal arterioles.
• A segmented, "boxcar" appearance of the retinal venules.
• Note: The actual causative embolism may or may not be visualized.
• External Visual Inspection: The pupil in the affected eye may be dilated and minimally reactive, or demonstrate a distinct afferent pupillary defect.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• The Time-to-Treatment Trap: A critical risk-stratification guideline dictates that visual decrement may be caused by a "low-flow" state rather than total occlusion. Because this cannot be definitively identified on presentation and can manifest hours later, immediate treatment and consultation are indicated regardless of the time of onset.
• Acute Stroke Pathway: Patients presenting with CRAO must be triaged as having an acute ischemic stroke equivalent. If a systemic stroke is suspected, activate your institution's acute stroke protocols immediately.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• The Lethal Trap (Anchoring on the Eye): Failing to recognize CRAO as a systemic cardiovascular event. Because it is a stroke equivalent, trainees often tunnel-vision on the eye and fail to evaluate the patient for concurrent, life-threatening cerebral or limb ischemia.
• The Triage Trap (Withholding Treatment): Delaying globe-salvaging maneuvers because the patient's symptom onset was hours ago. Immediate treatment is mandated regardless of the timeline, as the eye may be in a salvageable "low-flow" state.
• Critical Action: You must formally obtain and document visual acuity.
• Critical Action: Board examiners mandate that you secure an urgent/immediate ophthalmology consultation while concurrently initiating digital ocular massage and IOP-reducing medications in the ED.

7. MCQ MASTERCLASS (Written Exam Tips)

• Buzzword: "Sudden, painless monocular loss of vision" = CRAO.
• Buzzword: "Pale retina with a cherry-red spot" = CRAO.
• Buzzword: "Boxcar appearance of the retinal venules" = CRAO.
• Demographic Profile: Expect a question stem featuring an elderly patient (e.g., 67-year-old) with a heavy cardiovascular risk profile (hyperlipidemia, hypertension, and diabetes).
• Distractor Trap: A question will offer "retinal hemorrhages and dilated retinal veins" as an answer choice for a patient with painless vision loss. This describes CRVO ("blood and thunder"), not CRAO.
• Distractor Trap: "Pain with movement of the eye" or "sluggish mid-sized pupil with cloudy cornea" will be used to trick you. These describe optic neuritis and acute glaucoma, respectively, neither of which are painless.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

"My initial approach to this patient with sudden, painless monocular vision loss begins with assessing the ABCs to ensure there is no concurrent systemic embolic event, such as a cerebral stroke or limb ischemia, which would require immediate priority. I will formally obtain and document visual acuity and assess for an afferent pupillary defect. On my fundoscopic exam, I am specifically looking for a pale, edematous retina with a classic cherry-red spot at the fovea, which would confirm a Central Retinal Artery Occlusion. Because this is a time-sensitive ischemic stroke of the eye, I will immediately initiate globe-salvaging maneuvers, including digital ocular massage and topical beta-blockers to reduce intraocular pressure. I will consider the patient's eligibility for tPA based on our stroke center's protocols, assess for signs of Giant Cell Arteritis, and obtain a STAT ophthalmology consultation."